A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia - Related Studies

Home

A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia

This study has been completed.

Study NCT00088621. Last updated on June 23, 2005. Information provided by Sumitomo Pharmaceuticals America

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Schizophrenia

2	More general conditions related to this trial
		Mental Disorders
		Schizophrenia and Disorders with Psychotic Features

3	Interventions listed in this trial
		SM-13496

4	Sponsors listed in this trial
		Sumitomo Pharmaceuticals America